Dear John,

ICYMI, Health Affairs This Week featured Jeff Byers and Leslie Erdelack discussing recent cybersecurity events that have affected both health care businesses and patients alike, prevention measures, and what providers do when their technology tools aren't working.

Today's Featured Articles

The First-Ever Government Negotiation Process For Drugs Has Finished, But The Politics Are Ongoing

Tricia Neuman et al.

To Battle The Fentanyl Overdose Epidemic, Modernize Methadone Treatment

Thuy Nguyen et al.

Biosimilar Uptake In The US: Patient And Prescriber Factors

Dongzhe Hong et al.

More on Biosimilar Uptake

Benefit Design And Biosimilar Coverage In Medicare Part D: Evidence And Implications From Recent Reforms

Luca Bertuzzi and Luca Maini (May 2024)

part of our Eye On The IRA series

The Role Of Financial Incentives In Biosimilar Uptake In Medicare: Evidence From The 340B Program

Amelia M. Bond et al. (May 2023)

Regulatory And Cost Barriers Are Likely To Limit Biosimilar Development And Expected Savings In The Near Future

Henry G. Grabowski et al. (June 2014)

A Health Podyssey: Amelia Bond on 340B's Influence on Biosimilars (May 2023)

Kamyar Nasseh on the Growing Role of Private Equity in Dentistry

Health Affairs' Editor-in-Chief Alan Weil interviews Kamyar Nasseh of the American Dental Association on his recent study that identifies the growing role of private equity in dental practices.